248 related articles for article (PubMed ID: 18528865)
1. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.
Tsilidis KK; Branchini C; Guallar E; Helzlsouer KJ; Erlinger TP; Platz EA
Int J Cancer; 2008 Sep; 123(5):1133-40. PubMed ID: 18528865
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis.
Zhou B; Shu B; Yang J; Liu J; Xi T; Xing Y
Cancer Causes Control; 2014 Oct; 25(10):1397-405. PubMed ID: 25053407
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies.
Kakourou A; Koutsioumpa C; Lopez DS; Hoffman-Bolton J; Bradwin G; Rifai N; Helzlsouer KJ; Platz EA; Tsilidis KK
Cancer Causes Control; 2015 Oct; 26(10):1449-60. PubMed ID: 26220152
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and the risk of incident colorectal cancer.
Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ
JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037
[TBL] [Abstract][Full Text] [Related]
5. C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal Cancer.
Bodén S; Myte R; Harbs J; Sundkvist A; Zingmark C; Löfgren Burström A; Palmqvist R; Harlid S; Van Guelpen B
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1482-1491. PubMed ID: 32317300
[TBL] [Abstract][Full Text] [Related]
6. Circulating C-reactive protein and colorectal cancer risk: a report from the Shanghai Men's Health Study.
Wu J; Cai Q; Li H; Cai H; Gao J; Yang G; Zheng W; Xiang YB; Shu XO
Carcinogenesis; 2013 Dec; 34(12):2799-803. PubMed ID: 23985781
[TBL] [Abstract][Full Text] [Related]
7. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort.
Swede H; Hajduk AM; Sharma J; Rawal S; Rasool H; Vella AT; Tobet RE; Stevens RG
Int J Cancer; 2014 Apr; 134(8):1862-70. PubMed ID: 24122448
[TBL] [Abstract][Full Text] [Related]
8. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies.
Godos J; Biondi A; Galvano F; Basile F; Sciacca S; Giovannucci EL; Grosso G
World J Gastroenterol; 2017 Mar; 23(10):1909-1919. PubMed ID: 28348498
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein levels are not associated with increased risk for colorectal cancer in women.
Zhang SM; Buring JE; Lee IM; Cook NR; Ridker PM
Ann Intern Med; 2005 Mar; 142(6):425-32. PubMed ID: 15767620
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of serum C-reactive protein and colorectal cancer risk in men.
Gunter MJ; Stolzenberg-Solomon R; Cross AJ; Leitzmann MF; Weinstein S; Wood RJ; Virtamo J; Taylor PR; Albanes D; Sinha R
Cancer Res; 2006 Feb; 66(4):2483-7. PubMed ID: 16489056
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal Cancer.
Teras LR; Gapstur SM; Maliniak ML; Jacobs EJ; Gansler T; Michel A; Pawlita M; Waterboer T; Campbell PT
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):219-223. PubMed ID: 29254936
[No Abstract] [Full Text] [Related]
13. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
[TBL] [Abstract][Full Text] [Related]
14. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
[TBL] [Abstract][Full Text] [Related]
15. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.
Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487
[TBL] [Abstract][Full Text] [Related]
16. The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation.
Joshu CE; Tsilidis KK; Peskoe SB; Giardiello FM; Dluzniewski PJ; Nelson WG; Iacobuzio-Donahue CA; Platz EA
Cancer Causes Control; 2014 Apr; 25(4):409-18. PubMed ID: 24435936
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of plasma inflammatory markers and risk of colorectal cancer in men.
Song M; Wu K; Ogino S; Fuchs CS; Giovannucci EL; Chan AT
Br J Cancer; 2013 May; 108(9):1891-8. PubMed ID: 23591192
[TBL] [Abstract][Full Text] [Related]
18. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
20. Serum inflammatory markers and colorectal cancer risk and survival.
Ghuman S; Van Hemelrijck M; Garmo H; Holmberg L; Malmström H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
Br J Cancer; 2017 May; 116(10):1358-1365. PubMed ID: 28376082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
